A randomised, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.
| Autor: | Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW |
|---|---|
| Zdroj: | Sleep; 2009 Feb 1, Vol. 32 Issue 2, p159-168, 10p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|